Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1972 Nov;6(5):860–864. doi: 10.1128/iai.6.5.860-864.1972

Role of Complement in Immune Lysis of Trypanosoma cruzi

Dante F Anziano a, Agustin P Dalmasso a,1, Rosalia Lelchuk a, César Vásquez a
PMCID: PMC422621  PMID: 4564786

Abstract

Studies were performed on the mechanism of immune lysis of culture forms of Trypanosoma (Schizotrypanum) cruzi. Antibody-mediated lysis is caused by complement, which is activated via the classical pathway. The properdin system is not required. The kinetics of the reaction is similar to that followed by immune lysis of sensitized sheep erythrocytes, as is the concentration of divalent cations required for optimal lysis (0.15 mm Ca2+ and 0.5 mm Mg2+), the occurrence of cell membrane uptake of the complement components C3 and C4, and the development of characteristic ultrastructural modifications on the cell membrane.

Full text

PDF
861

Images in this article

862Image
on p.862

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BORSOS T., DOURMASHKIN R. R., HUMPHREY J. H. LESIONS IN ERYTHROCYTE MEMBRANES CAUSED BY IMMUNE HAEMOLYSIS. Nature. 1964 Apr 18;202:251–252. doi: 10.1038/202251a0. [DOI] [PubMed] [Google Scholar]
  2. BRENNER S., HORNE R. W. A negative staining method for high resolution electron microscopy of viruses. Biochim Biophys Acta. 1959 Jul;34:103–110. doi: 10.1016/0006-3002(59)90237-9. [DOI] [PubMed] [Google Scholar]
  3. Bladen H. A., Gewurz H., Mergenhagen S. E. Interactions of the complement system with the surface and endotoxic lipopolysaccharide of Veillonella alcalescens. J Exp Med. 1967 May 1;125(5):767–786. doi: 10.1084/jem.125.5.767. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Castellani O., Ribeiro L. V., Fernandes J. F. Differentiation of Trypanosoma cruzi in culture. J Protozool. 1967 Aug;14(3):447–451. doi: 10.1111/j.1550-7408.1967.tb02024.x. [DOI] [PubMed] [Google Scholar]
  5. Ensky J., Hinz C. F., Jr, Todd E. W., Wedgwood R. J., Boyer J. T., Lepow I. H. Properties of highly purified human properdin. J Immunol. 1968 Jan;100(1):142–158. [PubMed] [Google Scholar]
  6. González Cappa S. M., Schmuñis G. A., Traversa O. C., Yanovsky J. F., Parodi A. S. Complement-fixation tests, skin tests, and experimental immunization with antigens of Trypanosoma cruzi prepared under pressure. Am J Trop Med Hyg. 1968 Sep;17(5):709–715. doi: 10.4269/ajtmh.1968.17.709. [DOI] [PubMed] [Google Scholar]
  7. Goodkofsky I., Lepow I. H. Functional relationship of factor B in the properdin system to C3 proactivator of human serum. J Immunol. 1971 Oct;107(4):1200–1204. [PubMed] [Google Scholar]
  8. Lachmann P. J., Munn E. A., Weissmanng Complement-mediated lysis of liposomes produced by the reactive lysis procedure. Immunology. 1970 Dec;19(6):983–986. [PMC free article] [PubMed] [Google Scholar]
  9. Lelchuk R., Dalmasso A. P., Inglesini C. L., Alvarez M., Cerisola J. A. Immunoglobulin studies in serum of patients with American trypanosomiasis (Chagas' disease). Clin Exp Immunol. 1970 Apr;6(4):547–555. [PMC free article] [PubMed] [Google Scholar]
  10. MUELLER-EBERHARD H. J., BIRO C. E. ISOLATION AND DESCRIPTION OF THE FOURTH COMPONENT OF HUMAN COMPLEMENT. J Exp Med. 1963 Sep 1;118:447–466. doi: 10.1084/jem.118.3.447. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. MUNIZ J. [Immunity in Chagas' disease (trypanosomiasis americana)]. Mem Inst Oswaldo Cruz. 1962 Mar;60:103–147. doi: 10.1590/s0074-02761962000100006. [DOI] [PubMed] [Google Scholar]
  12. Müller-Eberhard H. J. Chemistry and reaction mechanisms of complement. Adv Immunol. 1968;8:1–80. doi: 10.1016/s0065-2776(08)60464-2. [DOI] [PubMed] [Google Scholar]
  13. NILSSON U. R., MUELLER-EBERHARD H. J. ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT. J Exp Med. 1965 Aug 1;122:277–298. doi: 10.1084/jem.122.2.277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. RUBIO M. Actividad lítica de sueros normales sobre formas de cultivo y sanguíneas de Trypanosoma cruzi. Bol Chil Parasitol. 1956 Oct-Dec;11(4):62–69. [PubMed] [Google Scholar]
  15. Sandberg A. L., Osler A. G., Shin H. S., Oliveira B. The biologic activities of guinea pig antibodies. II. Modes of complement interaction with gamma 1 and gamma 2-immunoglobulins. J Immunol. 1970 Feb;104(2):329–334. [PubMed] [Google Scholar]
  16. Strannegård O., Lycke E. Properdin and the antibody-effect on Toxoplasma gondii. Acta Pathol Microbiol Scand. 1966;66(2):227–238. doi: 10.1111/apm.1966.66.2.227. [DOI] [PubMed] [Google Scholar]
  17. TODD E. W., PILLEMER L., LEPOW I. H. The properdin system and immunity. IX. Studies on the purification of human properdin. J Immunol. 1959 Oct;83:418–427. [PubMed] [Google Scholar]
  18. WARREN L. G., BORSOS T. Studies on immune factors occurring in sera of chickens against the crithidia stage of Trypanosoma cruzi. J Immunol. 1959 Jun;82(6):585–590. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES